{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
NCT04266301: Phase 3 Interventional Completed Myelodysplastic Syndromes
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:golocdacimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03595059: Phase 1 Interventional Active, not recruiting Advanced Solid Tumors
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04087018: Phase 1 Interventional Completed Advanced Solid Tumors
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02877134: Phase 2 Interventional Completed Crohn Disease
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03938935: Not Applicable Interventional Unknown status Flexor Tendon Repair
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04501939: Phase 2 Interventional Active, not recruiting Chronic Lymphocytic Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:briquilimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04297995: Phase 2 Interventional Active, not recruiting Head and Neck Squamous Cell Carcinoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pivekimab sunirine [INN]
Source URL:
Class:
PROTEIN
